Abstract
lmost everyone agrees the world needs more Covid-19 vaccines. As we write, some countries have yet to administer even a single dose of vaccine, and current projections suggest many countries will have to wait until 2023 to start widespread vaccination.
Yet debate rages as to why the world is short on vaccines, and what barriers need to be overcome in order to make and distribute more. Intellectual property has become a flashpoint in the discussion.
Original language | Canadian English |
---|---|
Publication status | Published - Jan. 1 2021 |
Keywords
- Vaccines
- COVID-19
- Pharmaceutical Industry
- Global Health
Disciplines
- Food and Drug Law
- International Humanitarian Law
- Law
- Law and Society